Welcome to the e-CCO Library!

P321: Cessation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn’s Disease: Individual Patient Data Meta-Analysis of 323 patients from 12 studies
Year: 2021
Source: ECCO'21 Virtual
Authors: Ten Bokkel Huinink, S.(1);van der Woude, J.(1);Casanova, M.J.(2);Bouguen, G.(3);Mak, J.W.Y.(4);Molnar, T.(5);Seidelin, J.(6);Aurelien, A.(7);D'Haens, G.(8);Riviere, P.(9);Guidi, L.(10);Renata, B.(5);Lin, W.C.(11);de Vries, A.(12);
Created: Wednesday, 2 June 2021, 4:12 PM
P321: Increased modified DUBLIN scores are associated with serious ulcerative colitis and treatment failure
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Xie, C.(1)*;Su, J.(1);Liu, L.(1);Lin, Y.(1);Hu, Y.(1);Shi, H.(1);
Created: Friday, 14 July 2023, 11:05 AM
P321: Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn’s Disease (SIMCHA study): final results from a prospective, open-label, single-arm study
Year: 2022
Source: ECCO'22
Authors: Wetwittayakhlang, P.(1);Golovics , P.(1);Hahn, G.(1);Bessissow, T.(1); Afif, W.(1);Wild, G.(1);Bitton, A.(1);LakatosPhD, P.L.(1);
Created: Friday, 11 February 2022, 3:52 PM
P321: Mucosal healing in a cohort of inflammatory bowel diseases paediatric patients in clinical remission
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

F. P. Giugliano1, C. Strisciuglio*2, M. Martinelli1, M. Andreozzi1, S. Cenni1, A. Staiano1, E. Miele1

Created: Friday, 22 February 2019, 9:49 AM
P321: On effectiveness, safety, and TDM of thioguanine in a cohort of 274 patients with IBD, intolerant for conventional thiopurines
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Simsek*1, D. Deben2, C. S. Horjus3, M. Seinen1, C. J. Mulder1, D. R. Wong2, N. K. de Boer1, A. A. van Bodegraven4

Created: Friday, 22 February 2019, 9:41 AM
P321: Ulcerative colitis: Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting disease severity
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Jardak1*, M. Medhioub2, K. Agar2, L. Hamzaoui1,2,3, A. Khsiba2, M.M. Azouz2

Created: Thursday, 21 February 2019, 9:14 AM
P322 Impact of the presence of Epstein–Barr virus in intestinal mucosa of inflammatory bowel disease patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. NUÑEZ ORTIZ, C. Trigo Salado, M.D. De la Cruz Ramírez, J.L. Márquez Galán, J.M. Herrera Justiniano, E. Leo Carnerero

Created: Thursday, 30 January 2020, 10:12 AM
P322: A change in ΔMCV predicts mucosal healing in patients with Crohn's disease under combination therapy
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bernardo S., Fernandes S., Correia L., Velosa J.

Created: Wednesday, 20 February 2019, 10:36 AM
P322: Complications to parenteral therapy in patients with intestinal failure because of inflammatory bowel disease: A retrospective cohort study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

R. Lorentsen, L. K. Munck, S. Wildt*

Created: Friday, 22 February 2019, 9:49 AM
P322: Disease-related worries and concerns in patients with ulcerative colitis: 1-year data from ICONIC
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Ghosh*1, F. Casellas2, C. O’Shea3, K. Kligys4, J. Petersson4, L. Peyrin-Biroulet5

Created: Friday, 22 February 2019, 9:41 AM
P322: Effectiveness of Tumor Necrosis Factor-alpha inhibitors and Thiopurines combination therapy according to 6-thioguanine nucleotides plasma levels: A Systematic Review.
Year: 2022
Source: ECCO'22
Authors: Céspedes Martínez, E.(1);Robles, V.(1);Miarons, M.(2);Herrera-De Guise, C.(1);Mayorga-Ayala, L.(1);Perez, Z.(1);Oller, E.(1);Casellas, F.(1);Borruel, N.(1);
Created: Friday, 11 February 2022, 3:52 PM
P322: Hepatitis B reactivation under biologic therapy in patients with HBsAg negative phase of chronic HBV infection
Year: 2021
Source: ECCO'21 Virtual
Authors: Ergenç, I.(1);Kani, H.T.(1);Karabacak, M.(2);Cömert Özer, E.(3);Mehdiyev, S.(1);Jafarov, F.(1);Abacar, K.Y.(2);Kutluğ Ağaçkıran, S.(2);Seven Sevik, G.(2);Alibaz Öner, F.(2);İnanç, N.(2);Atagündüz, M.P.(2);Gençosmanoğlu, D.S.(3);Özen Alahdab, Y.(1);Ergun, T.(3);Direskeneli, R.H.(2);Atuğ, Ö.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P322: High body mass index and anaemia at diagnosis are predictors of extra-intestinal manifestations in children with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Yeushalmy-Feler*, S. Cohen

Created: Thursday, 21 February 2019, 9:14 AM
P322: Mycobiome signature in pediatric patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Murugesan, S.(1);Kumar, M.(1);Saadaoui, M.(1); Elhag, D.A.(1); Hendaus, M.A.(2); Ibrahim, N.(3); Al-Mudhaka, F.(3); AbuHazima, K.(3); Akobeng, A.(3);Elawad, M.(3);Al Khodor, S.(1)*;
Created: Friday, 14 July 2023, 11:05 AM
P323 Successful validation of the quantum blue quantitative rapid test to monitor C-reactive protein in capillary blood of patients suffering from chronic inflammatory diseases
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Takacs1, A. Hellige2, T. Schuster1, S. Schleifenbaum2, D. Föll2, J.M. Weber1

Created: Thursday, 30 January 2020, 10:12 AM
P323: Efficacy and safety of tofacitinib treatment for one year in Japanese patients with Ulcerative Colitis in a specialized Inflammatory Bowel Disease center
Year: 2021
Source: ECCO'21 Virtual
Authors: Kojima, K.(1);Yokoyama, K.(1);Kaku, K.(1);Takashima, Y.(1);Sato, T.(1);Kawai, M.(1);Kamikozuru, K.(1);Takagawa, T.(1);Yokoyama, Y.(1);Watanabe, K.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P323: Fatty liver assessment in inflammatory bowel disease patients using controlled attenuation parameter
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Balaban D.V.*1, Popp A.2,3,4, Robu G.5, Bucurica S.2,5, Costache R.S.2,5, Nuta P.5, Ionita Radu F.5,6, Jinga M.2,5

Created: Wednesday, 20 February 2019, 10:36 AM
P323: Prevalence of vitamin D deficiency in patients with inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

N. Toke*, P. Kakkadasam Ramaswamy, B. Sebastian, S. Mathai, C. Panackel

Created: Friday, 22 February 2019, 9:49 AM
P323: Prognostic factors for long-term adalimumab treatment
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Fumery*1, N. Duveau2, C. Perignon3, G. Lepeut4, A. Lahaye1, G. Le Baut1, C. Roussillon3, C. Yzet1, J. Loreau1, P. Wils4, M. Nachury4, B. Pariente4, S. Viennot3

Created: Friday, 22 February 2019, 9:41 AM
P323: The Crohn's Disease Exclusion Diet (CDED) for pouch inflammation: an interventional pilot study
Year: 2022
Source: ECCO'22
Authors: Fliss Isakov, N.(1);Kornblum, J.(1);Zemel, M.(2);Hirsch, A.(1);Maharshak, N.(1);
Created: Friday, 11 February 2022, 3:52 PM